Cell therapy is considered by some as the next frontier in cancer treatment, engineering patients' own immune systems to ...

But private sector companies like AstraZeneca are pushing forward with major investments in life sciences research and manufacturing. The Cambridge, U.K.-based pharmaceutical giant on Monday ...

AstraZeneca's 'smoker's lung' therapy meets main goals of late-stage asthma trials AstraZeneca said on Friday its triple-combination inhaler Breztri Aerosphere met all main goals in two late-stage ...

On Friday, AstraZeneca Plc (NASDAQ:AZN) reported topline data from Phase 3 KALOS and LOGOS trials in patients with uncontrolled asthma. KALOS and LOGOS trials assessed the efficacy and safety of ...

CAMBRIDGE, Britain — CAMBRIDGE, Britain — Astrazeneca PLC (AZN) on Tuesday reported first-quarter profit of $2.92 billion. On a per-share basis, the Cambridge, Britain-based company said it ...

Akeso's first overall survival readout for its Keytruda challenger caused a violent market reaction. AstraZeneca disclosed ...

British pharmaceutical giant AstraZeneca announced Tuesday that it has begun moving some of its European production to the United States, ahead of President Donald Trump's possible tariffs on the ...

China In April 2025, there are following developments in relation to the China investigations: First, in relation to the illegal drug importation allegations, AstraZeneca received an Appraisal ...